LOS ANGELES, CA, August 09, 2010 (Press-News.org) Once again proving success of their one on one approach to their client's tax needs Blue Tax continues to impact the industry in a positive manner.
An example of the high standards and quality service one can expect as a client of Blue Tax is the case of Juan R. of New York who came to Blue Tax with a Bank Levy for a 2005 tax liability of over $129,000. Juan hired Blue Tax to release his bank levy of over $3,645.73 and submit an amended 2005 return to the State of New York. The balance from the 2005 return came from the IRS reporting he had NY pension in the amount of $5,030 and e-trade for $ 705,653.
Blue Tax immediately contacted the State and provided them with an amended copy of the 2005 return as well as the IRS transcripts. Blue Tax then spoke with an audit group and based on the information they provided they were able to re-assess the 2005 balance. After the re-assessment the audit group found that the tax payer's liability was in fact only $3,095.91.Blue Tax was then able to partially release the bank levy. The bank at the time was holding $3,645.73 after the team at Blue Tax negotiated with the state agent an agreement was reached to release $549.82 back in to the taxpayer's bank account and the remainder of the funds would be applied to the balance and close out his debt.
The high standards in personal attention to clients throughout the process of resolution are paying off both for clients and Blue Tax. Blue Tax continues to rise above the rest by maintaining a unique approach to tax resolution by holding the client's needs above all else.
For more information about Blue Tax and its ability to help taxpayers resolve their tax problems, please visit
http://www.BlueTax.com or call (877) 316-1198 for a free confidential consultation.
Tax Resolution Firm Blue Tax Saves Client $126,000 Resolving Tax Debt to NY State Department of Taxation and Finance
Blue Tax pushes forward again this week with tax resolution for client in NY State.
2010-08-09
ELSE PRESS RELEASES FROM THIS DATE:
Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin
2010-08-09
Lampire Biological Laboratories (LBL) announced today that it signed an agreement with Proliant Health and Biologicals (Proliant), manufacturer of the worlds most trusted, high quality Bovine Serum Albumin (BSA), to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.
Stephen Welch, President & CEO of Proliant, said, "Proliant has become the pre-eminent bulk manufacturer of BSA, currently supplying over ...
Whataburger Asks Customers: "Tell Us Why You're Our Biggest Fan!"
2010-08-09
Southern burger icon Whataburger celebrates its 60th anniversary with its "Tell Us Why You're Our Biggest Fan" online contest. At stake is a Whataburger fan's dream come true: 60 years of free Whataburger, a trip to the Whataburger convention in Dallas, TX and other cool prizes!
Beginning August 4 and all throughout the company's anniversary month of August, fans can submit either videos or essays with photos at www.whataburger.com, demonstrating why they are Whataburger's biggest fans. The first 60 fans to enter will win a coupon for a free Whataburger.
The contest ...
LAST 30 PRESS RELEASES:
ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma
Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy
Drug combo cuts risk of death in advanced prostate cancer by 40%
ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors
Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer
ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients
ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients
New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease
Sylvester Cancer Tip Sheet for October 2025
Three science and technology leaders elected to Hertz Foundation Board of Directors
Jump Trading CSO Kevin Bowers elected to Hertz Foundation Board of Directors
Former Inscripta CEO Sri Kosaraju elected to Hertz Foundation Board of Directors
Citadel’s Jordan Chetty elected to Hertz Foundation Board of Directors
McGill research flags Montreal snow dump, inactive landfills as major methane polluters
A lightweight and rapid bidirectional search algorithm
Eighty-five years of big tree history available in one place for the first time
MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery
Health and economic air quality co-benefits of stringent climate policies
How immune cells deliver their deadly cargo
How the brain becomes a better listener: How focus enhances sound processing
Processed fats found in margarines unlikely to affect heart health
Scientists discover how leukemia cells evade treatment
Sandra Shi MD, MPH, named 2025 STAT Wunderkind
Treating liver disease with microscopic nanoparticles
Chemicals might be hitching a ride on nanoplastics to enter your skin
Pregnant patients with preexisting high cholesterol may have elevated CV risk
UC stroke experts discuss current and future use of AI tools in research and treatment
The Southern Ocean’s low-salinity water locked away CO2 for decades, but...
OHSU researchers develop functional eggs from human skin cells
[Press-News.org] Tax Resolution Firm Blue Tax Saves Client $126,000 Resolving Tax Debt to NY State Department of Taxation and FinanceBlue Tax pushes forward again this week with tax resolution for client in NY State.